• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

W135 型脑膜炎球菌性脑膜炎在加纳出现。

Emergence of W135 meningococcal meningitis in Ghana.

作者信息

Forgor Abudulai Adams, Leimkugel Julia, Hodgson Abraham, Bugri Akalifa, Dangy Jean-Pierre, Gagneux Sébastien, Smith Tom, Pluschke Gerd

机构信息

Navrongo Health Research Centre, Ministry of Health, Navrongo, Ghana.

出版信息

Trop Med Int Health. 2005 Dec;10(12):1229-34. doi: 10.1111/j.1365-3156.2005.01520.x.

DOI:10.1111/j.1365-3156.2005.01520.x
PMID:16359402
Abstract

Neisseria meningitidis serogroup W135, well known for a long time as a cause of isolated cases of meningococcal meningitis, has recently increasingly been associated with disease outbreaks of considerable magnitude. Burkina Faso was hit by W135 epidemics in the dry seasons of 2002-2004, but only four W135 meningitis cases were recorded between February 2003 and March 2004 in adjoining Ghana. This reconfirms previous findings that bottlenecks exist in the spreading of new epidemic N. meningitidis clones within the meningitis belt of sub-Saharan Africa. Of the four Ghanaian W135 meningitis patients one died and three survived, of whom one had profound neurosensory hearing loss and speech impairment. All four disease isolates were sensitive to penicillin G, chloramphenicol, ciprofloxacin and cefotaxime and had the multi-locus sequence type (ST) 11, which is the major ST of the ET-37 clonal complex. Pulsed-field gel electrophoresis (PFGE) profiles of the Ghanaian disease isolates and recent epidemic isolates from Burkina Faso were largely identical. We conducted meningococcal colonization surveys in the home communities of three of the patients and in the Kassena Nankana District located at the border to Burkina Faso. W135 carriage rates ranged between 0% and 17.5%. When three consecutive surveys were conducted in the patient community with the highest carrier rate, persistence of W135 colonization over a period of 1 year was observed. Differences in PFGE profiles of carrier isolates taken at different times in the same patient community were indicative of rapid microevolution of the W135 bacteria, emphasizing the need for innovative fine typing methods to reveal the relationship between W135 isolates.

摘要

脑膜炎奈瑟菌W135群长期以来一直被认为是散发性脑膜炎球菌性脑膜炎的病因,最近它与大规模疾病暴发的关联日益增加。布基纳法索在2002 - 2004年旱季遭受了W135疫情,但在毗邻的加纳,2003年2月至2004年3月期间仅记录到4例W135脑膜炎病例。这再次证实了先前的研究结果,即在撒哈拉以南非洲脑膜炎带内,新的流行性脑膜炎奈瑟菌克隆传播存在瓶颈。加纳的4例W135脑膜炎患者中,1例死亡,3例存活,其中1例有严重的神经感觉性听力丧失和言语障碍。所有4株疾病分离株对青霉素G、氯霉素、环丙沙星和头孢噻肟敏感,且具有多位点序列类型(ST)11,这是ET - 37克隆复合体的主要ST。加纳疾病分离株和布基纳法索近期流行分离株的脉冲场凝胶电泳(PFGE)图谱基本相同。我们在其中3例患者的家庭社区以及与布基纳法索接壤的卡塞纳 - 南卡纳区进行了脑膜炎球菌定植调查。W135携带率在0%至17.5%之间。在携带率最高的患者社区连续进行3次调查时,观察到W135定植持续了1年。在同一患者社区不同时间采集的携带菌分离株的PFGE图谱差异表明W135细菌发生了快速微进化,这强调了需要创新的精细分型方法来揭示W135分离株之间的关系。

相似文献

1
Emergence of W135 meningococcal meningitis in Ghana.W135 型脑膜炎球菌性脑膜炎在加纳出现。
Trop Med Int Health. 2005 Dec;10(12):1229-34. doi: 10.1111/j.1365-3156.2005.01520.x.
2
Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.南非出现与高死亡率相关的地方性W135群脑膜炎球菌病。
Clin Infect Dis. 2008 Feb 1;46(3):377-86. doi: 10.1086/525260.
3
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.2002 - 2005年布基纳法索流行性W135群脑膜炎奈瑟菌脑膜炎的兴衰
Clin Infect Dis. 2006 Oct 1;43(7):817-22. doi: 10.1086/507339. Epub 2006 Aug 22.
4
The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso.克隆复合体ET-37/ST-11的脑膜炎奈瑟菌W135血清群作为流行克隆的出现以及A血清群菌株在布基纳法索的持续存在。
Microbes Infect. 2005 Apr;7(4):645-9. doi: 10.1016/j.micinf.2005.01.003. Epub 2005 Mar 17.
5
Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.非洲脑膜炎带中的W135群脑膜炎球菌:流行病学、免疫与疫苗
Expert Rev Vaccines. 2006 Jun;5(3):319-36. doi: 10.1586/14760584.5.3.319.
6
Clonal spread of serogroup W135 meningococcal disease in Turkey.土耳其W135群脑膜炎球菌病的克隆传播
J Clin Microbiol. 2006 Jan;44(1):222-4. doi: 10.1128/JCM.44.1.222-224.2006.
7
Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan.摩洛哥、阿曼和苏丹朝觐者及其家庭接触者中W135群脑膜炎奈瑟菌的咽部携带情况。
APMIS. 2005 Mar;113(3):182-6. doi: 10.1111/j.1600-0463.2005.apm1130305.x.
8
Genetic diversification of Neisseria meningitidis during waves of colonization and disease in the meningitis belt of sub-Saharan Africa.撒哈拉以南非洲脑膜炎带脑膜炎奈瑟菌在多次定植和疾病流行期间的基因多样化。
Vaccine. 2007 Sep 3;25 Suppl 1:A18-23. doi: 10.1016/j.vaccine.2007.04.035. Epub 2007 May 7.
9
Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.2003年和2004年尼日尔脑膜炎球菌性脑膜炎的流行病学模式:在W135群脑膜炎奈瑟菌的威胁之下
Trop Med Int Health. 2005 May;10(5):435-43. doi: 10.1111/j.1365-3156.2005.01394.x.
10
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.加纳北部X群脑膜炎奈瑟菌暴发的前瞻性研究。
J Infect Dis. 2002 Mar 1;185(5):618-26. doi: 10.1086/339010. Epub 2002 Feb 14.

引用本文的文献

1
Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.非洲脑膜炎带中年龄相关的脑膜炎奈瑟菌携带情况:系统评价和荟萃分析。
Epidemiol Infect. 2019 Jan;147:e228. doi: 10.1017/S0950268819001134.
2
Loss of Genomic Diversity in a Neisseria meningitidis Clone Through a Colonization Bottleneck.脑膜炎奈瑟菌克隆通过定植瓶颈导致基因组多样性丧失。
Genome Biol Evol. 2018 Aug 1;10(8):2102-2109. doi: 10.1093/gbe/evy152.
3
Nasal carriage rate and antibiotic susceptibility pattern of Neisseria meningitidis in healthy Ethiopian children and adolescents: A cross-sectional study.
埃塞俄比亚健康儿童和青少年中脑膜炎奈瑟菌的鼻腔携带率及抗生素敏感性模式:一项横断面研究。
PLoS One. 2017 Oct 26;12(10):e0187207. doi: 10.1371/journal.pone.0187207. eCollection 2017.
4
Review of meningitis surveillance data, upper West Region, Ghana 2009-2013.加纳上西部地区2009 - 2013年脑膜炎监测数据回顾
Pan Afr Med J. 2016 Oct 1;25(Suppl 1):9. doi: 10.11604/pamj.supp.2016.25.1.6180. eCollection 2016.
5
The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.1994年至2012年非洲脑膜炎带中与疫情相关的W群脑膜炎奈瑟菌的建立与多样化
mSphere. 2016 Nov 16;1(6). doi: 10.1128/mSphere.00201-16. eCollection 2016 Nov-Dec.
6
Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.2015年尼日尔流行性C群脑膜炎奈瑟菌的出现:国家监测数据分析
Lancet Infect Dis. 2016 Nov;16(11):1288-1294. doi: 10.1016/S1473-3099(16)30253-5. Epub 2016 Aug 23.
7
Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA).比色法与定量氨基酸分析用于膜抗原通用模块(GMMA)蛋白质定量的比较。
Mol Biotechnol. 2015 Jan;57(1):84-93. doi: 10.1007/s12033-014-9804-7.
8
Climate change and cerebrospinal meningitis in the Ghanaian meningitis belt.气候变化与加纳脑膜炎带的脑脊髓膜炎
Int J Environ Res Public Health. 2014 Jul 7;11(7):6923-39. doi: 10.3390/ijerph110706923.
9
Neisseria meningitidis serogroup W, Burkina Faso, 2012.2012年,布基纳法索,W群脑膜炎奈瑟菌
Emerg Infect Dis. 2014 Mar;20(3):394-9. doi: 10.3201/eid2003.131407.
10
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.脑膜炎奈瑟菌结合因子 H 的流行株在非洲:对疫苗开发的影响。
PLoS Negl Trop Dis. 2011 Sep;5(9):e1302. doi: 10.1371/journal.pntd.0001302. Epub 2011 Sep 6.